【美股异动|Dexcom盘初一度涨近10% 血糖监测设备获美国FDA批准】医疗设备制造商Dexcom(DXCM.US)盘初一度涨近10%,现涨5.3%,报70.38美元。消息面上,Dexcom称美国FDA已批准其名为Dexcom G7 15 Day的15天连续血糖监测(CGM)设备在美国用于18岁以上的糖尿病患者。Dexcom预计将于2025年下半年在美国推出CGM。

金融界
10 Apr
医疗设备制造商Dexcom(DXCM.US)盘初一度涨近10%,现涨5.3%,报70.38美元。消息面上,Dexcom称美国FDA已批准其名为Dexcom G7 15 Day的15天连续血糖监测(CGM)设备在美国用于18岁以上的糖尿病患者。Dexcom预计将于2025年下半年在美国推出CGM。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10